Top Purchase Related
Home
>
Node
>
Subnode

Prophylaxis with co-trimoxazole for HIV infected adults in Africa

Anglaret, X.; Eholie, S.

Bmj 337: A304

2008

ISSN/ISBN: 1756-1833
PMID: 18614521
Document Number: 202440

Document emailed within 1 workday
Secure & encrypted payments

Bwakura-Dangarembizi, M.; Kendall, L.; Bakeera-Kitaka, S.; Nahirya-Ntege, P.; Keishanyu, R.; Nathoo, K.; Spyer, M.J.; Kekitiinwa, A.; Lutaakome, J.; Mhute, T.; Kasirye, P.; Munderi, P.; Musiime, V.; Gibb, D.M.; Walker, A.Sarah.; Prendergast, A.J. 2014: A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa New England Journal of Medicine 370(1): 41-53
Chintu, C.; Bhat, G.J.; Walker, A.S.; Mulenga, V.; Sinyinza, F.; Lishimpi, K.; Farrelly, L.; Kaganson, N.; Zumla, A.; Gillespie, S.H.; Nunn, A.J.; Gibb, D.M. 2004: Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial Lancet 364(9448): 1865-1871
Manyanga, V.P.; Minzi, O.; Ngasala, B. 2014: Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality Bmc Pharmacology and Toxicology 15: 24
Saadani Hassani, A.; Marston, B.J.; Kaplan, J.E. 2015: Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review Journal of Acquired Immune Deficiency Syndromes 68(Suppl 3): S257-S269
Pathai, S.; Gilbert, C.; Weiss, H.A.; Cook, C.; Wood, R.; Bekker, L.-G.; Lawn, S.D. 2013: Frailty in HIV-infected adults in South Africa Journal of Acquired Immune Deficiency Syndromes 62(1): 43-51
Chiller, T.M.; Polyak, C.S.; Brooks, J.T.; Williamson, J.; Ochieng, B.; Shi, Y.P.; Ouma, P.; Greene, C.; Hamel, M.; Vulule, J.; Bopp, C.; Slutsker, L.; Mintz, E. 2009: Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya Journal of the International Association of Physicians in Aids Care 8(3): 165-169
Yang, W.; Liang, Y.; Li, J.; Ma, Y.; Li, N.; Sun, D.; Wang, Z. 2014: Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy Zhonghua Liu Xing Bing Xue Za Zhi 35(6): 689-694
Murphy, R.A.; Marconi, V.C.; Gandhi, R.T.; Kuritzkes, D.R.; Sunpath, H. 2012: Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa Plos one 7(9): E44793
Martinson, N.; Mohapi, L.; Bakos, D.; Gray, G.E.; McIntyre, J.A.; Holmes, C.B. 2009: Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa Journal of Acquired Immune Deficiency Syndromes 50(3): 327-330
Audain, K.A.; Zotor, F.B.; Amuna, P.; Ellahi, B. 2015: Food supplementation among HIV-infected adults in Sub-Saharan Africa: impact on treatment adherence and weight gain Proceedings of the Nutrition Society 74(4): 517-525
Dlamini, J.; Ledwaba, L.; Mokwena, N.; Mokhathi, T.; Orsega, S.; Tsoku, M.; Kowo, H.; Proschan, M.; Khabo, P.; Maja, P.; Hadigan, C. 2011: Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa Antiviral Therapy 16(4): 605-609
Kakinami, L.; de Bruyn, G.; Pronyk, P.; Mohapi, L.; Tshabangu, N.; Moshabela, M.; McIntyre, J.; Martinson, N.A. 2011: The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa Aids and Behavior 15(4): 823-831
Zhu, Q.; Wang, L.; Lin, W.; Bulterys, M.; Yang, W.; Sun, D.; Cui, Z.; Kaplan, J.; Kleinman, N.; Wei, X.; Chung, J.; Wang, Z. 2014: Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China Current HIV Research 12(5): 359-365
Makubi, A.; Okuma, J.; Spiegelman, D.; Hawkins, C.; Darling, A.Marie.; Jackson, E.; Mugusi, F.; Chalamilla, G.; Fawzi, W. 2015: Burden and Determinants of Severe Anemia among HIV-Infected Adults: Results from a Large Urban HIV Program in Tanzania, East Africa Journal of the International Association of Providers of Aids Care 14(2): 148-155
Ahoua, L.; Umutoni, C.; Huerga, H.; Minetti, A.; Szumilin, E.; Balkan, S.; Olson, D.M.; Nicholas, S.; Pujades-Rodríguez, M. 2011: Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study Journal of the International Aids Society 14: 2
Thamprajamchit, S.; Chetchotisakd, P.; Thinkhamrop, B. 1998: Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study Journal of the Medical Association of Thailand 81(4): 265-271
Homsy, J.; Dorsey, G.; Arinaitwe, E.; Wanzira, H.; Kakuru, A.; Bigira, V.; Muhindo, M.; Kamya, M.R.; Sandison, T.G.; Tappero, J.W. 2014: Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial Lancet. Global Health 2(12): E727-E736
Donnelly, J.P.; Maschmeyer, G.; Daenen, S. 1992: Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group European Journal of Cancer 28a(4-5): 873-878
Maskew, M.; Macphail, A.Patrick.; Whitby, D.; Egger, M.; Wallis, C.L.; Fox, M.P. 2011: Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa Infectious Agents and Cancer 6: 22
Du Plessis, M.; von Gottberg, A.; Madhi, S.A.; Hattingh, O.; de Gouveia, L.; Klugman, K.P.; Vasaikar, S.; van Rensberg, N.J.; Moller, A.; Pretorius, A.-M.; Smith, P.; Ahmed, K.; Hoosen, A.; Lekalakala, R.; Ngwira, D.; Sein, P.P.; Crewe-Brown, H.; Feldman, C.; Karstaedt, A.; Perovic, O.; Wadula, J.; Dove, M.; Lindeque, K.; Meyer, L.; Weldhagen, G.; Bhola, P.; Moodley, P.; Seetharam, S.; Sithole, S.; Sturm, W.; Vanmali, T.; Hamese, K.; Bauer, K.; Hoyland, G.; Lebudi, J.; Mutanda, C.; Hoffman, R.; Liebowitz, L.; Wasserman, E.; Roditi, D.; Simpson, J.; Whitelaw, A.; Brink, A.; Heney, C.; Senekal, M.; Cohen, C.; Cheyip, M.; de Gouveia, L.; Frean, J.; Govender, N.; Keddy, K.; McCarthy, K.; Meiring, S.; Prentice, E.; Quan, V.; Soma, K.; von Gottbe 2008: Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa International Journal of Antimicrobial Agents 32(Suppl 1): S66-S70